Pharmaceutical company Endo International reaches a $7.5 million settlement with the Louisiana attorney general on all state government opioid claims.

Endo said the settlement includes no admission of wrongdoing by Endo or its subsidiaries.

Endo International has reportedly contacted a restructuring firm after thousands of opioid lawsuits.

Here are the biotech stocks to buy that we think will see magnified growth over the coming year. Real Money writer Bret Jensen reveals his top picks.

BioSpecifics, Front Yard Residential, Kaixin Auto Holdings, Trinseo and Centogene are some of Monday's top gainers.

"Supply chain challenges and persistent delays significantly limited the brand's responsive abilities" to changing consumer trends, CEO Sonia Syngal told investors Thursday.

"We believe the slowdown was caused by the spending pressure our consumers felt from higher gas prices and broader inflation," said CEO Bruce Thorn.

Costco took in $984 million in new membership fee in its fiscal third quarter, helping the bulk retailer top Street forecasts for topline revenues.